SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI.

Metra M, Tomasoni D, Adamo M, Amir O, Anker SD, Bayes-Genis A, Boehm M, Butler J, Chioncel O, Filippatos G, Gustafsson F, Jankowska EA, Kaski JC, Moura B, Petrie MC, Ponikowski P, Rakisheva A, Ristic A, Roubille F, Savarese G, Seferovic P, van der Meer P, Volterrani M, Coats AJ, Chopra VK, Rosano G

Open source

DOI: 10.1002/ehf2.15408
Published: 2025 Dec
Container: ESC heart failure
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ehf2.15408,
  title = {SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI.},
  author = {Metra M and Tomasoni D and Adamo M and Amir O and Anker SD and Bayes-Genis A and Boehm M and Butler J and Chioncel O and Filippatos G and Gustafsson F and Jankowska EA and Kaski JC and Moura B and Petrie MC and Ponikowski P and Rakisheva A and Ristic A and Roubille F and Savarese G and Seferovic P and van der Meer P and Volterrani M and Coats AJ and Chopra VK and Rosano G},
  year = {2025},
  journal = {ESC heart failure},
  doi = {10.1002/ehf2.15408},
  url = {https://doi.org/10.1002/ehf2.15408}
}

RIS

TY  - JOUR
TI  - SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI.
AU  - Metra M
AU  - Tomasoni D
AU  - Adamo M
AU  - Amir O
AU  - Anker SD
AU  - Bayes-Genis A
AU  - Boehm M
AU  - Butler J
AU  - Chioncel O
AU  - Filippatos G
AU  - Gustafsson F
AU  - Jankowska EA
AU  - Kaski JC
AU  - Moura B
AU  - Petrie MC
AU  - Ponikowski P
AU  - Rakisheva A
AU  - Ristic A
AU  - Roubille F
AU  - Savarese G
AU  - Seferovic P
AU  - van der Meer P
AU  - Volterrani M
AU  - Coats AJ
AU  - Chopra VK
AU  - Rosano G
PY  - 2025
JO  - ESC heart failure
DO  - 10.1002/ehf2.15408
UR  - https://doi.org/10.1002/ehf2.15408
ER  -

APA

M, M., D, T., M, A., O, A., SD, A., A, B., M, B., J, B., O, C., G, F., F, G., EA, J., JC, K., B, M., MC, P., P, P., A, R., A, R., F, R., G, S., P, S., P, V. D. M., M, V., AJ, C., VK, C., & G, R. (2025). SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI.. ESC heart failure. https://doi.org/10.1002/ehf2.15408

Source records

pubmed · retrieved 2026-09-26T05:00:43.479Z